INTERIM ANALYSIS OF 2-LEVEL BAGUERA® C IDE STUDY MEETS THRESHOLD FOR NON-INFERIORITY
GENEVA, April 16, 2025 /PRNewswire/ -- Spineart, a fast-growing company in spine surgery innovation, today announces that it has completed a planned interim analysis for its 2-level BAGUERA® C IDE